Although a variety of organizations, including the U.S. Pharmacopeial Convention (USP), have published guidelines and standards on compounding and handling sterile medications, poor adherence to such standards and an absence of formal infection control policies at many outpatient oncology facilities have resulted in serious patient harm, according to experts speaking at a recent CDC webinar.
More than 80% of the 1.7 million people diagnosed with cancer each year receive treatment in a community